StonvexLoading…
StonvexStonvexStonvexCore line items from FSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $673.91M | $625.60M | $2.18B | $1.58B | $1.03B |
Operating Income | Not available | $99.70M | $340.90M | $257.40M | $163.40M |
Net Income | Not available | $70.40M | $246.60M | $185.80M | $117.70M |
EPS (Diluted) | $1.30 | $1.14 | $4.01 | $3.02 | $1.91 |
Total Assets | Not available | $2.45B | $2.39B | $1.94B | $1.92B |
Total Liabilities | Not available | $1.02B | $1.01B | $616.70M | $653.80M |
Cash & Equivalents | Not available | $71.40M | $63.70M | $54.40M | $64.70M |
Free Cash Flow OCF − CapEx | Not available | $94.60M | $227.10M | $137.60M | $83.50M |
Shares Outstanding | Not available | 61.50M | 60.90M | 61.50M | 61.60M |